Lucintel Forecasts Regenerative Medicine Market To Reach $10 Billion By 2030

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to the recent study the regenerative medicine market is projected to reach an estimated $10 billion by 2030 at a CAGR of 3% from 2024 to 2030. Growth in this market is primarily driven by increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.
Browse 94 figures/charts and 87 tables in this 184-page report to understand trends, opportunities and forecast in regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, and others, product (cell-based immunotherapy & cell therapy products, tissue-engineered products, and others), application (musculoskeletal disorders, wound care, and other applications), distribution channel (hospitals, clinics, and others), and region.
Download sample by clicking on regenerative medicine market
Lucintel ...
... forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.
Kite Pharma, Novartis, Vericel, Integra LifeSciences, Wright Medical, MiMedx, Osiris Therapeutics, Stryker, Spark Therapeutics, and Zimmer Biomet are the major suppliers in the regenerative medicine market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Train Battery Market in Canada
Two Wheeler Hub Motor Market in Canada
Used Car Market in Canada
Vertical Top Loading Cartoning Machine Market in Canada
Well Testing Service Market in Canada
Copper Cathode Market in Canada